Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 50, Issue 7-8, Pages 1042-1051Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2007.01.009
Keywords
TCA-cycle; aspartate; glutamate; glutamine; metabolism; hepatic encephalopathy; energy; glucose
Categories
Ask authors/readers for more resources
Cerebral hyperammonemia is a hallmark of hepatic encephalopathy, a debilitating condition arising secondary to liver disease. Pyruvate oxidation including tricarboxylic acid (TCA) cycle metabolism has been suggested to be inhibited by hyperammonemia at the pyruvate and a-ketoglutarate dehydrogenase steps. Catabolism of the branched-chain amino acid isolencine provides both acetyl-CoA and succinyl-CoA, thus by-passing both the pyruvate dehydrogenase and the a-ketoglutarate dehydrogenase steps. Potentially, this will enable the TCA cycle to work in the face of ammonium-induced inhibition. In addition, this will provide the a-ketoglutarate carbon skeleton for glutamate and glutamine synthesis by glutamate dehydrogenase and glutamine synthetase (astrocytes only), respectively, both reactions fixing ammonium. Cultured cerebellar neurons (primarily glutamatergic) or astrocytes were incubated in the presence of either [U-C-13]glucose (2.5 mM) and isoleucine (1 mM) or [U-C-13]isoleucine and glucose. Cell cultures were treated with an acute ammonium chloride load of 2 (astrocytes) or 5 mM (neurons and astrocytes) and incorporation of C-13-label into glutamate, aspartate, glutamine and alanine was determined employing mass spectrometry. Labeling from [U-C-13]glucose in glutamate and aspartate increased as a result of ammonium-treatment in both neurons and astrocytes, suggesting that the TCA cycle was not inhibited. Labeling in alanine increased in neurons but not in astrocytes, indicating elevated glycolysis in neurons. For both neurons and astrocytes, labeling from [U-C-13]isoleucine entered glutamate and aspartate albeit to a lower extent than from [U-C-13]glucose. Labeling in glutamate and aspartate from [U-C-13]isoleucine was decreased by ammonium treatment in neurons but not in astrocytes, the former probably reflecting increased metabolism of unlabeled glucose. In astrocytes, ammonia treatment resulted in glutamine production and release to the medium, partially supported by catabolism of [U-C-13]isoleucine. In conclusion, i) neuronal and astrocytic TCA cycle metabolism was not inhibited by ammonium and ii) isoleucine may provide the carbon skeleton for synthesis of glutamate/glutamine in the detoxification of ammonium. (C) 2007 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available